Loading...
•
Mar 31, 2024
Alphatec Q1 2024 Earnings Report
Total revenue increased by 27%, driven by 30% growth in surgical revenue, and adjusted EBITDA margin expanded by 450 basis points.
Key Takeaways
Alphatec Holdings, Inc. reported strong first-quarter 2024 financial results, with total revenue growing 27% to $138 million and surgical revenue increasing by 30%. The company also raised its full-year revenue and adjusted EBITDA guidance to $601 million and $23 million, respectively.
Surgical revenue grew 30% with a 23% increase in surgical volume and a 6% increase in average revenue per procedure.
Hosted 150 surgeon training engagements, fueling a 21% growth in surgeon adoption and increasing utilization.
Continued to elevate U.S. footprint with expansion in several major markets and 28% growth in established territories.
Deployed approximately $60 million of revenue-generating assets to capitalize on market opportunity.
Forward Guidance
For the full year 2024, the Company now expects total revenue to grow 25% to $601 million, including surgical revenue of $536 million and EOS revenue of $65 million. The Company also expects non-GAAP adjusted EBITDA of approximately $23 million.
Positive Outlook
- Total revenue expected to grow 25% to $601 million.
- Surgical revenue expected to be $536 million.
- EOS revenue expected to be $65 million.
- Non-GAAP adjusted EBITDA expected to be approximately $23 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...